Logo image of ALTO

ALTO INGREDIENTS INC (ALTO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALTO - US0215131063 - Common Stock

2.84 USD
-0.19 (-6.27%)
Last: 12/29/2025, 8:00:00 PM
2.82 USD
-0.02 (-0.7%)
After Hours: 12/29/2025, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, ALTO scores 2 out of 10 in our fundamental rating. ALTO was compared to 83 industry peers in the Chemicals industry. The financial health of ALTO is average, but there are quite some concerns on its profitability. ALTO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALTO has reported negative net income.
ALTO had a negative operating cash flow in the past year.
ALTO had negative earnings in 4 of the past 5 years.
ALTO had a positive operating cash flow in 4 of the past 5 years.
ALTO Yearly Net Income VS EBIT VS OCF VS FCFALTO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

ALTO's Return On Assets of -13.24% is on the low side compared to the rest of the industry. ALTO is outperformed by 78.31% of its industry peers.
ALTO has a Return On Equity of -23.13%. This is in the lower half of the industry: ALTO underperforms 74.70% of its industry peers.
Industry RankSector Rank
ROA -13.24%
ROE -23.13%
ROIC N/A
ROA(3y)-10.14%
ROA(5y)-4.95%
ROE(3y)-17.06%
ROE(5y)-8.78%
ROIC(3y)N/A
ROIC(5y)N/A
ALTO Yearly ROA, ROE, ROICALTO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

Looking at the Gross Margin, with a value of 1.99%, ALTO is doing worse than 91.57% of the companies in the same industry.
ALTO's Gross Margin has declined in the last couple of years.
ALTO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.6%
GM growth 5YN/A
ALTO Yearly Profit, Operating, Gross MarginsALTO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 -6

More info and screens

4

2. Health

2.1 Basic Checks

ALTO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALTO has more shares outstanding than it did 1 year ago.
ALTO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALTO has a worse debt to assets ratio.
ALTO Yearly Shares OutstandingALTO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALTO Yearly Total Debt VS Total AssetsALTO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.44, we must say that ALTO is in the distress zone and has some risk of bankruptcy.
ALTO has a Altman-Z score of 0.44. This is amonst the worse of the industry: ALTO underperforms 80.72% of its industry peers.
ALTO has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, ALTO is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 0.44
ROIC/WACCN/A
WACC13.4%
ALTO Yearly LT Debt VS Equity VS FCFALTO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 3.56 indicates that ALTO has no problem at all paying its short term obligations.
ALTO has a Current ratio of 3.56. This is amongst the best in the industry. ALTO outperforms 86.75% of its industry peers.
ALTO has a Quick Ratio of 2.30. This indicates that ALTO is financially healthy and has no problem in meeting its short term obligations.
ALTO's Quick ratio of 2.30 is amongst the best of the industry. ALTO outperforms 86.75% of its industry peers.
Industry RankSector Rank
Current Ratio 3.56
Quick Ratio 2.3
ALTO Yearly Current Assets VS Current LiabilitesALTO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ALTO have decreased strongly by -32.69% in the last year.
ALTO shows a decrease in Revenue. In the last year, the revenue decreased by -8.00%.
The Revenue has been decreasing by -7.49% on average over the past years.
EPS 1Y (TTM)-32.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%575%
Revenue 1Y (TTM)-8%
Revenue growth 3Y-7.2%
Revenue growth 5Y-7.49%
Sales Q2Q%-4.3%

3.2 Future

Based on estimates for the next years, ALTO will show a very strong growth in Earnings Per Share. The EPS will grow by 34.90% on average per year.
Based on estimates for the next years, ALTO will show a quite strong growth in Revenue. The Revenue will grow by 12.23% on average per year.
EPS Next Y82.8%
EPS Next 2Y39.45%
EPS Next 3Y34.9%
EPS Next 5YN/A
Revenue Next Year-3.23%
Revenue Next 2Y2.26%
Revenue Next 3Y12.23%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALTO Yearly Revenue VS EstimatesALTO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ALTO Yearly EPS VS EstimatesALTO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALTO. In the last year negative earnings were reported.
Also next year ALTO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALTO Price Earnings VS Forward Price EarningsALTO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALTO indicates a slightly more expensive valuation: ALTO is more expensive than 65.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.48
ALTO Per share dataALTO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as ALTO's earnings are expected to grow with 34.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.45%
EPS Next 3Y34.9%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALTO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ALTO INGREDIENTS INC

NASDAQ:ALTO (12/29/2025, 8:00:00 PM)

After market: 2.82 -0.02 (-0.7%)

2.84

-0.19 (-6.27%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-03 2026-03-03/amc
Inst Owners28.34%
Inst Owner Change-7%
Ins Owners4.88%
Ins Owner Change4.11%
Market Cap219.65M
Revenue(TTM)922.31M
Net Income(TTM)-51.45M
Analysts82.5
Price Target4.34 (52.82%)
Short Float %0.82%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.02
Dividend Growth(5Y)-2.34%
DP-2.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)199.31%
Min EPS beat(2)-40.06%
Max EPS beat(2)438.68%
EPS beat(4)2
Avg EPS beat(4)8.57%
Min EPS beat(4)-385.93%
Max EPS beat(4)438.68%
EPS beat(8)3
Avg EPS beat(8)-45.05%
EPS beat(12)4
Avg EPS beat(12)-82.89%
EPS beat(16)6
Avg EPS beat(16)-778.96%
Revenue beat(2)1
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-4.23%
Max Revenue beat(2)0.24%
Revenue beat(4)2
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)4.09%
Revenue beat(8)3
Avg Revenue beat(8)-0.97%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)9
Avg Revenue beat(16)1.06%
PT rev (1m)0%
PT rev (3m)6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)42.86%
EPS NY rev (1m)65%
EPS NY rev (3m)65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.85%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 1.02
EV/EBITDA 15.48
EPS(TTM)-0.69
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS11.93
BVpS2.88
TBVpS2.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.24%
ROE -23.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.99%
FCFM N/A
ROA(3y)-10.14%
ROA(5y)-4.95%
ROE(3y)-17.06%
ROE(5y)-8.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.6%
GM growth 5YN/A
F-Score3
Asset Turnover2.37
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 5.41
Cap/Depr 15.44%
Cap/Sales 0.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.56
Quick Ratio 2.3
Altman-Z 0.44
F-Score3
WACC13.4%
ROIC/WACCN/A
Cap/Depr(3y)107.88%
Cap/Depr(5y)83.14%
Cap/Sales(3y)2.13%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%575%
EPS Next Y82.8%
EPS Next 2Y39.45%
EPS Next 3Y34.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-8%
Revenue growth 3Y-7.2%
Revenue growth 5Y-7.49%
Sales Q2Q%-4.3%
Revenue Next Year-3.23%
Revenue Next 2Y2.26%
Revenue Next 3Y12.23%
Revenue Next 5YN/A
EBIT growth 1Y71.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year241.25%
EBIT Next 3Y64.22%
EBIT Next 5YN/A
FCF growth 1Y55.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.14%
OCF growth 3YN/A
OCF growth 5YN/A

ALTO INGREDIENTS INC / ALTO FAQ

Can you provide the ChartMill fundamental rating for ALTO INGREDIENTS INC?

ChartMill assigns a fundamental rating of 2 / 10 to ALTO.


What is the valuation status of ALTO INGREDIENTS INC (ALTO) stock?

ChartMill assigns a valuation rating of 1 / 10 to ALTO INGREDIENTS INC (ALTO). This can be considered as Overvalued.


How profitable is ALTO INGREDIENTS INC (ALTO) stock?

ALTO INGREDIENTS INC (ALTO) has a profitability rating of 1 / 10.


How sustainable is the dividend of ALTO INGREDIENTS INC (ALTO) stock?

The dividend rating of ALTO INGREDIENTS INC (ALTO) is 0 / 10 and the dividend payout ratio is -2.46%.